452 related articles for article (PubMed ID: 26116874)
1. Maternal obesity and neuroprotective magnesium sulfate.
McPherson J; Smiley S; Stamilio D
Am J Obstet Gynecol; 2015 Oct; 213(4):582.e1-6. PubMed ID: 26116874
[TBL] [Abstract][Full Text] [Related]
2. Association of Maternal Obesity with Child Cerebral Palsy or Death.
McPherson JA; Smid MC; Smiley S; Stamilio DM
Am J Perinatol; 2017 May; 34(6):563-567. PubMed ID: 27855463
[No Abstract] [Full Text] [Related]
3. Effect of obesity on neonatal outcomes in pregnancies with preterm premature rupture of membranes.
Faucett AM; Metz TD; DeWitt PE; Gibbs RS
Am J Obstet Gynecol; 2016 Feb; 214(2):287.e1-287.e5. PubMed ID: 26435047
[TBL] [Abstract][Full Text] [Related]
4. Association of duration of neuroprotective magnesium sulfate infusion with neonatal and maternal outcomes.
McPherson JA; Rouse DJ; Grobman WA; Palatnik A; Stamilio DM
Obstet Gynecol; 2014 Oct; 124(4):749-755. PubMed ID: 25198275
[TBL] [Abstract][Full Text] [Related]
5. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial.
Crowther CA; Hiller JE; Doyle LW; Haslam RR;
JAMA; 2003 Nov; 290(20):2669-76. PubMed ID: 14645308
[TBL] [Abstract][Full Text] [Related]
6. School-age outcomes of very preterm infants after antenatal treatment with magnesium sulfate vs placebo.
Doyle LW; Anderson PJ; Haslam R; Lee KJ; Crowther C;
JAMA; 2014 Sep; 312(11):1105-13. PubMed ID: 25226476
[TBL] [Abstract][Full Text] [Related]
7. Proximity of magnesium exposure to delivery and neonatal outcomes.
Turitz AL; Too GT; Gyamfi-Bannerman C
Am J Obstet Gynecol; 2016 Oct; 215(4):508.e1-6. PubMed ID: 27177525
[TBL] [Abstract][Full Text] [Related]
8. Maternal side effects & fetal neuroprotection according to body mass index after magnesium sulfate in a multicenter randomized controlled trial.
Vilchez G; Dai J; Lagos M; Sokol RJ
J Matern Fetal Neonatal Med; 2018 Jan; 31(2):178-183. PubMed ID: 28056569
[TBL] [Abstract][Full Text] [Related]
9. Magnesium sulfate, chorioamnionitis, and neurodevelopment after preterm birth.
Kamyar M; Manuck TA; Stoddard GJ; Varner MW; Clark E
BJOG; 2016 Jun; 123(7):1161-6. PubMed ID: 26036660
[TBL] [Abstract][Full Text] [Related]
10. Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: An individual participant data meta-analysis.
Crowther CA; Middleton PF; Voysey M; Askie L; Duley L; Pryde PG; Marret S; Doyle LW;
PLoS Med; 2017 Oct; 14(10):e1002398. PubMed ID: 28976987
[TBL] [Abstract][Full Text] [Related]
11. Mode of delivery at periviability and early childhood neurodevelopment.
Običan SG; Small A; Smith D; Levin H; Drassinower D; Gyamfi-Bannerman C
Am J Obstet Gynecol; 2015 Oct; 213(4):578.e1-4. PubMed ID: 26116869
[TBL] [Abstract][Full Text] [Related]
12. Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis.
Costantine MM; Weiner SJ;
Obstet Gynecol; 2009 Aug; 114(2 Pt 1):354-364. PubMed ID: 19622997
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of implementing magnesium sulphate for neuroprotection in a tertiary obstetric unit.
Ow LL; Kennedy A; McCarthy EA; Walker SP
Aust N Z J Obstet Gynaecol; 2012 Aug; 52(4):356-60. PubMed ID: 22515404
[TBL] [Abstract][Full Text] [Related]
14. Intrapartum magnesium for prevention of cerebral palsy: continuing controversy?
Cahill AG; Stout MJ; Caughey AB
Curr Opin Obstet Gynecol; 2010 Apr; 22(2):122-7. PubMed ID: 20179596
[TBL] [Abstract][Full Text] [Related]
15. Magnesium sulphate and perinatal mortality and morbidity in very-low-birthweight infants born between 24 and 32 weeks of gestation in Japan.
Ohhashi M; Yoshitomi T; Sumiyoshi K; Kawagoe Y; Satoh S; Sameshima H; Ikenoue T
Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():140-5. PubMed ID: 27131232
[TBL] [Abstract][Full Text] [Related]
16. Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia.
Grether JK; Hoogstrate J; Walsh-Greene E; Nelson KB
Am J Obstet Gynecol; 2000 Sep; 183(3):717-25. PubMed ID: 10992199
[TBL] [Abstract][Full Text] [Related]
17. Immediate clinical outcomes in preterm neonates receiving antenatal magnesium for neuroprotection.
Basu SK; Chickajajur V; Lopez V; Bhutada A; Pagala M; Rastogi S
J Perinat Med; 2011 Aug; 40(2):185-9. PubMed ID: 21834608
[TBL] [Abstract][Full Text] [Related]
18. Prenatal Tobacco Exposure and Childhood Neurodevelopment among Infants Born Prematurely.
Robbins LS; Blanchard CT; Sinkey RG; Harris SL; Tita AT; Harper LM
Am J Perinatol; 2021 Feb; 38(3):218-223. PubMed ID: 32862421
[TBL] [Abstract][Full Text] [Related]
19. Antenatal magnesium sulfate and neuroprotection.
Doyle LW
Curr Opin Pediatr; 2012 Apr; 24(2):154-9. PubMed ID: 22227787
[TBL] [Abstract][Full Text] [Related]
20. Intrapartum magnesium sulfate is associated with neuroprotection in growth-restricted fetuses.
Stockley EL; Ting JY; Kingdom JC; McDonald SD; Barrett JF; Synnes AR; Monterrosa L; Shah PS; ; ;
Am J Obstet Gynecol; 2018 Dec; 219(6):606.e1-606.e8. PubMed ID: 30240651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
